Disease progression and adverse events in patients listed for elective percutaneous coronary intervention

Postgraduate Medical Journal

Volumn 81, Issue 957, 2005, Pages 459-462

  Talwar, S ^a   Karpha, M ^a   Thomas, R ^a   Vurwerk, C ^a   Cox, I C ^a   Burrell, C J ^a   Motwani, J G ^a   Gilbert, T J ^a   Haywood, G A ^a  

^a DERRIFORD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEATH; DISEASE COURSE; FEMALE; FOLLOW UP; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; REVASCULARIZATION; TIME; UNSTABLE ANGINA PECTORIS;

ADULT; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COLLATERAL CIRCULATION; CORONARY DISEASE; DISEASE PROGRESSION; EMERGENCIES; ENGLAND; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; REMISSION, SPONTANEOUS; SURGICAL PROCEDURES, ELECTIVE; WAITING LISTS;

EID: 22344436576     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2004.031344     Document Type: Article

References (26)

1. Chester M, Chen L, Kaski JC. Identification of patients at high risk for adverse coronary events while awaiting routine coronary angioplasty. Br Heart J 1995;73:216-22.
2. Bucher HC, Hengstler P, Schindler C, et al. Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials. BMJ 2000;321:73-7.
3. Naylor CD, Sykora K, Jaglal SB, et al. Waiting for CABG: population based study of 8517 consecutive patients in Ontario, Canada. Lancet 1995;346:1605-9.
4. Silber S, Muhling H, Dorr R, et al. Waiting times and death on the waiting list for CABG operations: experience in Munich with over 1000 patients. (In German.) Herz, 1996;21:389-96.
5. Bengston A, Karlsson T, Hjalmarson A, et al. Complications prior to revascularisation among patients waiting for CABG and PTCA. Eur Heart J 1996;17:1846-51.
6. Morgan CD, Sykora K, Naylor CD, for the steering committee of the Cardiac Care Network of Ontario. Analysis of deaths while waiting for cardiac surgery among 29,293 consecutive patients in Ontario, Canada. Heart 1998;79:345-9.
7. Suttorp MJ, Kingma JH, Vos J, et al. Determinants for early mortality in patients awaiting CABG: a case control study. Eur Heart J 1992;13:238-42.
8. Moise A, Theroux P, Taeymans Y, et al. Clinical and angiographic factors associated with progression of coronary artery disease. J Am Coll Cardiol 1984;3:659-67.
9. Moise A, Lesperance J, Theroux P, et al. Clinical and angiographic predictors of new total coronary occlusion in coronary artery disease: analysis of 313 nonoperated patients. Am J Cardiol 1984;54:1176-81.
10. Brown B, Zhao XQ, Sacco DE, et al. Lipid lowering and plaque regression: new insights into prevention of plaque disruption and clinical events in coronary disease. Circulation 1993;87:1781-91.
11. Taeymans Y, Theroux P, Lesperance J, et al. Quantitative angiographic morphology of the coronary artery lesions at risk of thrombotic occlusion. Circulation 1992;85:78-85.
12. De Feyter PY, Serruys PW. PTCA for unstable angina. In: Topol EJ, ed. Textbook of interventional cardiology. 2nd ed. Philadelphia: W B Sounders, 1994:274-91.
13. Kaski JC, Chen L, Chester M. Rapid angiographic progression of "target" and "nontarget" stenosis in patients awaiting coronary angioplasty. J Am Coll Cardiol 1995;26:416-21.
14. Rosanio S, Tocchi M, Cutler D, et al. Queuing for coronary angiography during severe supply-demand mismatch in a US public hospital: analysis of a waiting list registry. JAMA 1999;282:145-52.
15. Department of Health. National Service Framework for coronary heart disease. London: Department of Health, 2000.
16. Lichtlen P, Nikutta P, Jost S, et al. Anatomical progression of coronary artery disease in humans as seen by prospective, repeated, quantitated coronary angiography: relation to clinical events and risk factors. Circulation 1992;86:828-38.
17. Bemis CE, Gorlin R, Kemp HG, et al. Progression of coronary artery disease. A clinical arteriographic study. Circulation 1973;47:455-64.
18. Bruschke AV, Wijers TS, Kolsters W, et al. The anatomic evolution of coronary artery disease demonstrated by coronary arteriography in 256 non-operated patients. Circulation 1981;63:527-36.
19. Singh R. Progression of coronary atherosclerosis. Clues to pathogenesis from serial coronary arteriography. Br Heart J 1984;52:451-61.
20. Ambrose JA, Tannenbaum MA, Alexopoulos D, et al. Angiographic progression of coronary disease and the development of MI. J Am Coll Cardiol 1988;12:56-62.
21. Taeymans Y, Theroux P, Lesperance J, et al. Quantitative angiographic morphology of the coronary artery lesions at risk of thrombotic occlusion. Circulation 1992;85:78-85.
22. Kaski JK, Chester MR, Chen L, et al. Rapid angiographic progression of coronary artery disease in patients with angina pectoris. The role of complex stenosis morphology. Circulation 1995;92:2058-65.
23. Cox ID, Schwartzman RA, Atienza F, et al. Angiographic progression in patients with angina pectoris and normal or near normal coronary angiograms who are restudied due to unstable symptoms. Eur Heart J 1998;19:1027-33.
24. Moise A, Theroux P, Taeymans Y, et al. Unstable angina and progression of coronary atherosclerosis. N Engl J Med 1983;309:685-9.
25. Heistad DD. Unstable coronary artery plaques. N Engl J Med 2003;349:2285-8.
26. Fulton WFM. The time factor in the enlargement of anastomosis in coronary artery disease. Scott Med J 1964;9:18-23.